Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by Sdmsdmon May 19, 2015 2:39pm
101 Views
Post# 23741817

RE:RE:M&A activity in Generics

RE:RE:M&A activity in Generics
Oooh a little thin skinned aren't you shorty. Me thinks the "schooling'' jibe maybe hit home?
 
You talk about investing but that is not what you do. You clearly don't understand investing. You may have an understanding of trading (I really don't know) but I think most here would agree they are different beasts.
 
The only thing you really seem to have a talent for is spreading fear, uncertainty and doubt on bulletin boards (probably for a living??).
 
Would I rather see no insider sales - sure. But management and board are still significant shareholders here and their interests and that of shareholders seem pretty well aligned for the moment. I don't begrudge a guy (CEO) in his late 40s/early 50s taking a little bit off the table to buy a house.
 
Regarding being stuck. Fortunately I am not. I was lucky enough to get in back in late Dec/early Jan. I thank Dart and MMN for that. I also bought more at 26 cents and 34 cents. I will buy more over the coming weeks.
 
All I see is young business with great prospects in  good sector where the management team are largely doing what they said they would do. I'm happy to wait 18-24 months for a bigger pay off so the day to day nonsense (the sort of stuff you are responsible for) doesn't really bother me too much. 
Bullboard Posts